m-CTG: A low cost mobile-phone cardiotocograph device for antenatal and intrapartum monitoring to prevent perinatal mortality in low resource settings

The INCLEN Trust International
Organization Location: 
New Delhi, India

Still birth and birth hypoxia remain challenge for many developing countries including India. Appropriate monitoring is important to detect the at-risk mothers and fetuses for complicated labour, fetal distress, birth hypoxia, still birth and neonatal death. Cardiotocography (CTG) is widely used for monitoring in later pregnancy and during labor to detect at-risk mothers and fetuses. CTG device or Doppler FHR monitor is not available at most of the public health facilities in India. Availability of CTG devices and tools at lower level facilities and with health workers shall enable assessment and identification of the high risk cases for early referral and appropriate action to reduce still birth, birth asphyxia and neonatal mortality. We propose developing a mobile phone based CTG (m-CTG) with inbuilt algorithm and alerts that can be used to identify the at-risk fetuses and monitor high-risk pregnant women for early referral and appropriate action. The proposed cheaper m-CTG device (cost ~$100-120) shall have the functions of standard CTG devices including FHR, fetal movements and uterine contraction. The in-built algorithm shall allow categorization to identify the abnormal ones. This device shall be mobile/ portable and easy to handle. Real-time data transmission by the mobile device shall allow referral and action for high risk cases. Other m-Health applications can be easily integrated for comprehensive and single window continuum service delivery. This shall enforce standardize case management and protocol adherence. On successful development, industry partnership will enable mass scale production and marketing along with adoption in the public health system.

See video